FDA Drug Application (020986) for NOVOLOG INNOLET by NOVO NORDISK INC

Back to FDA Applications sponsored by NOVO NORDISK INC

Application Number020986
Product Number004
FormINJECTABLE;SUBCUTANEOUS
Dosage300 UNITS/3ML (100 UNITS/ML)
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNOVOLOG INNOLET
Active IngredientINSULIN ASPART RECOMBINANT



Back to FDA Applications sponsored by NOVO NORDISK INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.